OmniAb (OABI) Treasury Shares (2022 - 2026)
OmniAb (OABI) reported Treasury Shares of $2.2 million for Q1 2026, up 1.72% year-over-year from $2.1 million in Q1 2025, and up 34.18% on a QoQ basis from $1.6 million in Q4 2025.
OmniAb (OABI) has 5 years of Treasury Shares data on file, last reported at $2.2 million in Q1 2026.
- Quarterly Treasury Shares rose 1.72% year-over-year to $2.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 million (up 1.72% YoY) and the FY2025 annual result came in at $1.6 million, down 7.48% from the prior year.
- Treasury Shares improved to $2.2 million in Q1 2026 per OABI's latest filing, from $1.6 million in the prior quarter.
- Across five years, Treasury Shares topped out at $2.3 million in Q1 2024 and bottomed at $94749.0 in Q4 2022.
- The 5-year median for Treasury Shares is $1.9 million (2023), against an average of $1.4 million.
- The widest annual swing landed in 2024, when Treasury Shares jumped 2353.23%; it then slipped 7.54% in 2025.
- Tracing OABI's Treasury Shares over 5 years: stood at $94749.0 in 2022, then surged by 1882.48% to $1.9 million in 2023, then dropped by 6.24% to $1.8 million in 2024, then slipped by 7.48% to $1.6 million in 2025, then surged by 34.18% to $2.2 million in 2026.
- Per Business Quant, the three latest OABI Treasury Shares figures stand at $2.2 million (Q1 2026), $1.6 million (Q4 2025), and $2.0 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | 265,401.92 |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 700,000.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 34.70 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | OmniAb | 334.72 Mn | 291.75 Mn | 14.41 Mn | 2.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.19 Mn |
| Mar 31, 2026 | 2.19 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Jun 30, 2025 | 2.03 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Mar 31, 2025 | 2.15 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Dec 31, 2024 | 1.76 Mn |
| Sep 30, 2024 | 94,749.00 |
| Sep 30, 2024 | 94,749.00 |
| Jun 30, 2024 | 2.08 Mn |
| Jun 30, 2024 | 2.08 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Mar 31, 2024 | 2.32 Mn |
| Dec 31, 2023 | 1.88 Mn |
| Dec 31, 2023 | 1.88 Mn |
| Sep 30, 2023 | 94,749.00 |
| Sep 30, 2023 | 94,749.00 |
| Jun 30, 2023 | 2.16 Mn |
| Jun 30, 2023 | 2.16 Mn |
| Mar 31, 2023 | 94,749.00 |
| Mar 31, 2023 | 94,749.00 |
| Dec 31, 2022 | 94,749.00 |
| Dec 31, 2022 | 94,749.00 |